Eric Bourhis

Eric Bourhis, Ph.D., is currently the Head of Business Development for Immunology, Metabolism, Cardiovascular, and Renal at Genentech in South San Francisco. In this role, they facilitate partnerships from early-stage research through late-stage clinical development. Eric earned a Ph.D. in Biochemistry and Cell Biology from Marseille University, France, and began their career at Genentech in 2005 in the Protein Engineering department, progressing through various roles related to portfolio management and partnering. They have also held positions at Gilead Sciences and Bellicum Pharmaceuticals, contributing significantly to drug development and collaboration efforts across the industry.